The2^ndHIVSummitintheMiddleEastaccredited by the Health Authority of Abu Dhabi and supported by Gilead Sciences has seen over100international and Middle EastexpertsconveneinDubaion December 15 and 16, 2017. The Summit, entitled ‘Today’s Choices – Tomorrow’s Health’discussedrecent updates and developments in the field of Human Immunodeficiency Virus (HIV)intheregion.

Dr.Samer El-Ali, Medical Director, Gilead Sciences Eastern Europe and Middle East stated:“For the second consecutive year, HIV Summit gathered leading infectious disease experts committed to the exchange of know-how and best practices focused on HIV management. Our ambition is to provide healthcare community in the Middle East a platform for continuous education on the effective HIV treatment, which leads to the better support for the people affected by HIV across the region.”